GB:XDG3 ETF Price & Analysis
XDG3 ETF Chart & Stats
$35.82
--
Market closed
$35.82
--
Day’s Range― - ―
52-Week Range$30.22 - $38.94
Previous Close$35.82
VolumeN/A
Average Volume (3M)619.00
AUM25.58M
NAV35.95
Expense Ratio0.35%
Holdings Count116
Beta0.80
Inception DateJan 18, 2023
Next Dividend Ex-DateN/A
Dividend Yield
(―)Shares OutstandingN/A
Standard DeviationN/A
10 Day Avg. Volume144
30 Day Avg. Volume619
AlphaN/A
ETF Overview
Xtrackers MSCI Global SDG 3 Good Health UCITS ETF
The Xtrackers MSCI Global SDG 3 Good Health UCITS ETF, with the ticker GB:XDG3, is a specialized investment vehicle designed to provide exposure to the global healthcare sector. This ETF focuses on companies that are aligned with Sustainable Development Goal 3 (SDG 3) – ensuring healthy lives and promoting well-being for all at all ages. As a sector-focused, broad-based niche fund, it offers investors a unique opportunity to invest in a diverse range of healthcare companies that are committed to advancing global health initiatives. The Xtrackers MSCI Global SDG 3 Good Health UCITS ETF carefully selects its holdings from a universe of companies that demonstrate strong potential for innovation and growth within the healthcare industry. This ETF not only allows investors to tap into the financial potential of the healthcare sector but also to align their portfolios with sustainable development priorities, making it an attractive option for socially-conscious investors seeking both impact and returns.
Xtrackers MSCI Global SDG 3 Good Health UCITS ETF (XDG3) Fund Flow Chart
Xtrackers MSCI Global SDG 3 Good Health UCITS ETF (XDG3) 1 year Net Flows: -$27M
XDG3 ETF News
XDG3 ETF FAQ
What was GB:XDG3’s price range in the past 12 months?
GB:XDG3 lowest ETF price was $30.22 and its highest was $38.94 in the past 12 months.
What is the AUM of GB:XDG3?
As of Mar 16, 2026 The AUM of GB:XDG3 is 25.58M.
Is GB:XDG3 overvalued?
According to Wall Street analysts GB:XDG3’s price is currently Undervalued.
Does GB:XDG3 pay dividends?
GB:XDG3 does not currently pay dividends.
How many shares outstanding does GB:XDG3 have?
Currently, no data Available
Which hedge fund is a major shareholder of GB:XDG3?
Currently, no hedge funds are holding shares in GB:XDG3
XDG3 ETF Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
Amgen Inc
4.70%
Vertex Pharmaceuticals Inc.
4.68%
Eli Lilly And Company
4.58%
Abbvie
4.56%
Bristol-Myers Squibb Company
4.55%
Merck & Company
4.55%
Stryker Corp
4.54%
Gilead Sciences
4.48%
AstraZeneca plc
4.37%
Danaher Corporation
4.27%
Total45.29%
See All Holdings

